XORTX Therapeutics Inc. Made Big Gain
Wed, Jul 13, 2022 at 08:33 PM
XORTX Therapeutics Inc. (XRTX:NASDAQ) shot up at $1.81, a gain of 47.2%. On Wed, Jul 13, 2022, XRTX:NASDAQ hit a New 2-Week High of $1.81. The stock got featured on our News Catalysts scanner on Wed, Jul 13, 2022 at 10:16 AM in the 'BIOTECH' category. From Thu, Jun 30, 2022, the stock recorded 25.00% Up Days and 22.22% Green Days
The stock spiked on Tue, May 03, 2022 at $2.29 with a volume of 4M+.
About XORTX Therapeutics Inc. (XRTX:NASDAQ)
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which...
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 47.15%
- ironSource Ltd. Class A (IS:NYSE), 47.09%
- TDH Holdings, Inc. (PETZ:NASDAQ), 42.23%
- NuCana plc (NCNA:NASDAQ), 41.4%
- Gossamer Bio, Inc. (GOSS:NASDAQ), 31.9%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 31.48%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 24.34%
- The OLB Group, Inc. (OLB:NASDAQ), 23.86%
- Velo3D Inc. (VLD:NYSE), 22.22%
- CinCor Pharma Inc. (CINC:NASDAQ), 21.13%